# An Open, Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin Versus Cefuroxime Alone or With Oral Erythromycin for the Treatment of Chinese Patients Who Were Hospitalized for Pneumonia

> **NCT00648726** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 139 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** cefuroxime plus erythromycin
- **DRUG:** azithromycin (Zithromax)
- **DRUG:** cefuroxime

## Key facts

- **NCT ID:** NCT00648726
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** 2003-08
- **Target enrollment:** 139 (ACTUAL)
- **Last updated:** 2008-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00648726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00648726, "An Open, Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Intravenous Followed by Oral Azithromycin Versus Cefuroxime Alone or With Oral Erythromycin for the Treatment of Chinese Patients Who Were Hospitalized for Pneumonia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00648726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*